Treatment with N-acetyl-L-leucine beneficial for Niemann-Pick disease
Treatment with N-acetyl-L-leucine (NALL) for 12 weeks yields better neurological status than placebo among patients with genetically confirmed Niemann-Pick disease type C, according to a study published in the Feb. 1 issue ...
Feb 1, 2024
0
0